Matrix metalloproteinases and their expression in mammary gland

Cell Research

Volumn 8, Issue 3, 1998, Pages 187-194

  Uria, Jose A ^a,b   Werb, Zena ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer progression; ECM; Mammary gland; Matrix metalloproteinases

Indexed keywords

METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL; BIOSYNTHESIS; BREAST; ENZYMOLOGY; EXTRACELLULAR MATRIX; HUMAN; PHYSIOLOGY; REVIEW; UDDER;

ANIMALS; BREAST; EXTRACELLULAR MATRIX; HUMANS; MAMMARY GLANDS, ANIMAL; METALLOENDOPEPTIDASES; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0032160115     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/cr.1998.19     Document Type: Article

References (20)

1. Werb Z. ECM and cell surface proteolysis: Regulating cellular ecology. Cell 1997; 91:439-42.
2. Stetler-Stevenson WG, Aznovoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993; 9:541-73.
3. Birkedal-Hansen H, Moore WG, Bodden MK et al. Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 1993; 4:197-250.
4. Basset P, Okada A, Chenard MP et al. Matrix metalloproteinases as stromal effectors of human carcinoma progression: Therapeutic implications. Matrix Biol 1997; 15:535-41.
5. Halpert I, Sires U, Roby J et al. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc Natl Acad Sci USA 1996; 93:9748-53.
6. Chandler S, Miller KM, Clements JM et al. Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview. J Neuroimmunol 1997; 72:155-61.
7. Coussens LM, Werb Z. Matrix metalloproteinases and the development of cancer. Chem Biol 1996; 3:895-904.
8. Springman EB, Angleton EL, Birkedal-Hansen H, Van Wart HE. Multiple modes of activation of latent human fibroblast collagenase: Evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc Natl Acad Sci USA 1990; 87:364-8.
9. Pei D, Weiss SJ. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 1995; 375:244-7.
10. Murphy G, Knauper V. Relating matrix metalloproteinase structure to function: why the "hemopexin" domain? Matrix Biol 1997; 15:511-8.
11. Sternlicht M, Werb Z. In: Kreis T, Vale R eds Guidebook to the extracellular matrix and adhesion proteins, 2nd ed. Oxford University Press: Oxford, 1998; in press.
12. Basbaum C, Werb Z. Focalized proteolysis and temporal regulation of extracellular matrix degradation at the cell surface. Curr Opin Cell Biol 1996; 8:731-8.
13. Douglas D, Shi E, Sang Q. Computational sequence analysis of the tisue inhibitor of metalloproteinase family. J Prot Chem 1997; 16:237-55.
14. Witty JP, Wright JH, Matrisian L. Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol Biol Cell 1995; 6:1287-303.
15. Talhouk RS, Bissell MJ, Werb Z. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J Cell Biol 1992; 118:1271-82.
16. Lund LR, Romer J, Thomasset N et al. Two distinct phases of apoptosis in mammary gland involution: Proteinase-independent and -dependent pathways. Development 1996; 122: 181-93.
17. Sympson CJ, Talhouk RS, Alexander CM, Chin JR, Clift SM, Bissell MJ, Werb Z. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol 1994; 125:681-93.
18. Alexander CM, Howard EW, Bissell MJ, Werb Z. Rescue of epithelial cell apoptosis and entactin degradation by a TIMP-1 transgene. J Cell Biol 1996; 135:1669-77.
19. Sympson CJ, Bissell MJ, Werb Z. Mammary gland tumor formation in transgenic mice overexpressing stromelysin-1. Sem Cancer Biol 1997; 6:159-63.
20. Lochter A, Srebow A, Sympson CJ, Terracio N, Werb Z, Bissell MJ. Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties. J Biol Chem 1997; 272:5007-15.